Abstract
The development of deoxynucleoside triphosphate (dNTP)-based drugs requires a quantitative understanding of any inhibition, activation, or hydrolysis by off-target cellular enzymes. SAMHD1 is a regulatory dNTP-triphosphohydrolase that inhibits HIV-1 replication in human myeloid cells. We describe here an enzyme-coupled assay for quantifying the activation, inhibition, and hydrolysis of dNTPs, nucleotide analogues, and nucleotide analogue inhibitors by triphosphohydrolase enzymes. The assay facilitates mechanistic studies of triphosphohydrolase enzymes and the quantification of off-target effects of nucleotide-based antiviral and chemotherapeutic agents.
Copyright © 2015, Arnold et al.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acid Anhydride Hydrolases / analysis*
-
Acid Anhydride Hydrolases / genetics
-
Acid Anhydride Hydrolases / metabolism
-
Acyclovir / chemistry
-
Acyclovir / metabolism
-
Acyclovir / pharmacology
-
Adenine Nucleotides / chemistry
-
Adenine Nucleotides / pharmacology
-
Antiviral Agents / chemistry
-
Antiviral Agents / metabolism
-
Antiviral Agents / pharmacology
-
Arabinonucleosides / chemistry
-
Arabinonucleosides / pharmacology
-
Biological Assay / methods*
-
Catalysis / drug effects
-
Clofarabine
-
Deoxyribonucleotides / chemistry
-
Deoxyribonucleotides / metabolism
-
Dose-Response Relationship, Drug
-
Drug Evaluation, Preclinical / methods*
-
Ganciclovir / chemistry
-
Ganciclovir / pharmacology
-
HIV-1
-
Hydrolysis
-
Monomeric GTP-Binding Proteins / analysis*
-
Monomeric GTP-Binding Proteins / metabolism*
-
SAM Domain and HD Domain-Containing Protein 1
Substances
-
Adenine Nucleotides
-
Antiviral Agents
-
Arabinonucleosides
-
Deoxyribonucleotides
-
Clofarabine
-
SAM Domain and HD Domain-Containing Protein 1
-
SAMHD1 protein, human
-
Acid Anhydride Hydrolases
-
exopolyphosphatase
-
Monomeric GTP-Binding Proteins
-
Ganciclovir
-
Acyclovir